CD4 and neoplasm: In the subcutaneous MC38 tumor model, anti–PD-1 treatment caused tumor regression, while progressive tumor expansion was observed in the Gsdmdfl/fl CD4cre mice after anti–PD-1 treatment, indicating the importance of GSDMD activation in CD4+ T cells for the therapeutic effectiveness (Figure 7K).